未登录 Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study risankizumab在中度至重度活动性克罗恩病患者中的疗效和安全性: 序列开放标签扩展研究的中期结果 Peyrin-Biroulet, Laurent; Atreya, Raja; Danese, Silvio; Lindsay, James O.; Chapman, J. Casey; Anschutz, Toni; Huang, Xiu; Zambrano, Javier; van Haaren, Stijn; Joshi, Namita; Duan, W. Rachel; Cross, Raymond K. 分享 收藏
分享 收藏
Developing an adaptive platform trial for evaluation of medical treatments for Crohn's disease 开发一个适应性平台试验，用于评估克罗恩病的医疗治疗方法 Noor, Nurulamin M.; Radford, Shellie J.; Choodari-Oskooei, Babak; Gordon, Morris; Hart, Ailsa L.; Hepburn, Trish; Juszczak, Ed; Lindsay, James O.; Kennedy, Nicholas A.; Parmar, Mahesh K. B.; Jairath, Vipul; Moran, Gordon W. 分享 收藏
分享 收藏
Trans-continental analysis of determinants of response to COVID-19 vaccination in 2268 patients with Inflammatory Bowel Disease Wong, S. Y.; Moran, H. R.; Rajauria, P.; Giselbrecht, E.; Wellens, J.; Vermiere, S.; Watanabe, K.; Kamikozuru, K.; Halfvarson, J.; Bergemalm, D.; Silverberg, M. S.; Ng, S. C.; Mak, J. W. Y.; Ahuja, V; Virmani, S.; Kedia, S.; Lindsay, J. O.; Abreu, M. T.; Allez, M.; Rubin, D. T.; Dutta, U.; Sinha, S. K.; Sharma, V; Samanta, J.; Shah, J.; Singh, A. K.; Kaur, H.; Kaplan, G.; Thompson, C.; Colombel, J. F.; Satsangi, J. 分享 收藏
Impact of Risankizumab on Patient-reported Outcomes and Biomarkers Over Time: Post-Hoc Analysis of Phase 3 INSPIRE and COMMAND Studies Lindsay, J.; Ferrante, M.; Armuzzi, A.; Peyrin-Biroulet, L.; Dubinsky, M. C.; Danese, S.; Garrison, A.; Yafei, Z.; Kalabic, J.; Remple, V; Vladea, R.; Sharma, D.; Panaccione, R. 分享 收藏
Use of FK-adalimumab biosimilar (MSB 11022) in context of biologic switch in Inflammatory Bowel Diseases: 6 months data of the real-world IDEA study Peyrin-Biroulet, L.; Bouhnik, Y.; Hebuterne, X.; Fumery, M.; Taxonera, C.; Gutierrez-Casbas, A.; Howaldt, S.; Stein, J.; Lindsay, J.; Monnet, J.; Simoes, E.; Dolfi, F. 分享 收藏
Emulsifier restriction does not impair nutrient intake and improves food-related quality of life in active Crohn's disease: dietary analysis of the ADDapt randomised controlled trial Buckley, A.; Xu, Y.; Burke, S.; Bancil, A.; Sandall, A.; Cox, S.; Rucco, V; Kelaiditis, C.; Gibson, R.; Chassaing, B.; Rossi, M.; Lindsay, J.; Whelan, K. 分享 收藏
Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease: Results From the One-Year SEQUENCE Open-Label Long-Term Extension Peyrin-Biroulet, L.; Atreya, R.; Danese, S.; Lindsay, J. O.; Chapman, J. C.; Anschutz, T.; Huang, X.; Zambrano, J.; Platt, A.; Joshi, N.; Cross, R. K. 分享 收藏
Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease With 3 Years of Treatment: Results From the FORTIFY Open-Label Long-Term Extension Ferrante, M.; Panaccione, R.; Colombel, J. F.; Dubinsky, M. C.; Hisamatsu, T.; Lindsay, J. O.; Song, A.; Yao, Y.; Zhang, Y.; Zambrano, J.; Aponte, F.; Duan, W. R.; D'Haens, G. 分享 收藏
Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross-sectional survey Roukas, Chris; Miller, Laura; Buttner, Fionn Cleirigh; Hamborg, Thomas; Stagg, Imogen; Hart, Alisa; Gordeev, Vladimir Sergeevich; Lindsay, James O.; Norton, Christine; Mihaylova, Borislava 分享 收藏
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure Upadacitinib在克罗恩病中实现了临床和内镜结果，无论先前的生物暴露如何 Peyrin-Biroulet, Laurent; Panaccione, Remo; Louis, Edouard; Atreya, Raja; Rubin, David T.; Lindsay, James O.; Siffledeen, Jesse; Lukin, Dana J.; Wright, John; Watanabe, Kenji; Ford, Sharanya; Remple, Valencia P.; Lacerda, Ana P.; Dubcenco, Elena; Garrison, Andrew; Zhou, Qian; Berg, Sofie; Anyanwu, Samuel I.; Schreiber, Stefan 分享 收藏
Impact of Prior Biologic Exposure on the Durability of Ozanimod Over 5 Years of Continuous Treatment in Patients With Ulcerative Colitis: An Interim Analysis of the True North Open-Label Extension Study Sands, Bruce E.; Oneto, Caterina; Borman, Zachary A.; Syal, Gaurav; Ungaro, Ryan C.; Ferrante, Marc; Lindsay, James O.; Blumenstein, Irina; Liu, Zhaohui; Mehra, Dimpy; Jain, Anjali; D'Haens, Geert R. 分享 收藏
Sustained Efficacy and Safety After 5 Years of Continuous Ozanimod Treatment Independent of Clinical Remission Status: An Interim Analysis of the True North Open-Label Extension Study 奥扎尼妥(Ozanimod)连续治疗5年后的持续疗效与安全性：True North开放标签扩展研究的期中分析 Cross, RK; Danese, S; Wolf, DC; Matsuoka, K; Dotan, I; Boland, BS; Raffals, LE; Mehra, D; Santiago, NR; Petersen, A; Desai, M; Wu, HAL; Wang, D; Osterman, MT; Jain, A; Lindsay, JO 分享 收藏
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease Peyrin-Biroulet, Laurent; Chapman, J. Casey; Colombel, Jean-Frederic; Caprioli, Flavio; D'Haens, Geert; Ferrante, Marc; Schreiber, Stefan; Atreya, Raja; Danese, Silvio; Lindsay, James O.; Bossuyt, Peter; Siegmund, Britta; Irving, Peter M.; Panaccione, Remo; Cao, Qian; Neimark, Ezequiel; Wallace, Kori; Anschutz, Toni; Kligys, Kristina; Duan, W. Rachel; Pivorunas, Valerie; Huang, Xiu; Berg, Sofie; Shu, Lei; Dubinsky, Marla 分享 收藏
Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials Siegel, Corey A.; Rai, Victoria; Outtier, An; Vermeire, Severine; Law, Cindy C. W.; Sands, Bruce E.; Abdulhamid, Asim; Gearry, Richard; McGuire, Josh; Lindsay, James O.; Panaccione, Remo; Schweistein, Hagai; Dotan, Iris; Scarallo, Luca; Griffiths, Anne; Dubinsky, Marla C. 分享 收藏
分享 收藏
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial Noor, Nurulamin M.; Lee, James C.; Bond, Simon; Dowling, Francis; Brezina, Biljana; Patel, Kamal, V; Ahmad, Tariq; Banim, Paul J.; Berrill, James W.; Cooney, Rachel; Negro, Juan De La Revilla; de Silva, Shanika; Din, Shahida; Durai, Dharmaraj; Gordon, John N.; Irving, Peter M.; Johnson, Matthew; Kent, Alexandra J.; Kok, Klaartje B.; Moran, Gordon W.; Mowat, Craig; Patel, Pritash; Probert, Chris S.; Raine, Tim; Saich, Rebecca; Seward, Abigail; Sharpstone, Dan; Smith, Melissa A.; Subramanian, Sreedhar; Upponi, Sara S.; Wiles, Alan; Williams, Horace R. T.; van den Brink, Gijs R.; Vermeire, Severine; Jairath, Vipul; D'Haens, Geert R.; McKinney, Eoin F.; Lyons, Paul A.; Lindsay, James; Kennedy, Nicholas A.; Smith, Kenneth G. C.; Parkes, Miles 分享 收藏
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial 自体造血干细胞移植联合低剂量环磷酰胺动员和低强度预处理与标准治疗难治性克罗恩病的安全性和有效性 (ASTIClite): 一项开放标签、多中心、随机对照试验 Lindsay, James O.; Hind, Daniel; Swaby, Lizzie; Berntsson, Hannah; Bradburn, Mike; Bannur, C. Uday; Byrne, Jennifer; Clarke, Christopher; Desoysa, Lauren; Dickins, Ben; Din, Shahida; Emsley, Richard; Foulds, Gemma A.; Gribben, John; Hawkey, Christopher; Irving, Peter M.; Kazmi, Majid; Lee, Ellen; Loban, Amanda; Lobo, Alan; Mahida, Yashwant; Moran, Gordon W.; Papaioannou, Diana; Parkes, Miles; Peniket, Andrew; Pockley, A. Graham; Satsangi, Jack; Subramanian, Sreedhar; Travis, Simon; Turton, Emily; Uttenthal, Ben; Rutella, Sergio; Snowden, John A. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏